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ARTICLE
Immunoglobulin G antibodies against Porphyromonas gingivalis or
Aggregatibacter actinomycetemcomitans in cardiovascular disease and
periodontitis
Christian Damgaard a,b, Jesper Reinholdtc, Christian Enevoldb, Nils-Erik Fiehnd, Claus Henrik Nielsenb
and Palle Holmstrupa
aSection of Periodontology, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen,
Copenhagen, Denmark; bInstitute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen
University Hospital, Copenhagen, Denmark; cDepartment of Biomedicine, Faculty of Health Sciences, Aarhus University, Aarhus,
Denmark; dDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen,
Copenhagen, Denmark
ABSTRACT
Objectives: The aim was to elucidate whether levels of circulating antibodies to Actinobacillus
actinomycetemcomitans and Porphyromonas gingivalis correlate to loss of attachment, as a
marker for periodontitis and cardiovascular disease (CVD).
Design: Sera were collected from 576 participants of the Danish Health Examination Survey
(DANHES). Immunoglobulin G antibodies against lipopolysaccharide (LPS) and protein antigens
from the a, b and c serotypes of A. actinomycetemcomitans and P. gingivalis were quantified by
titration in ELISA plates coated with a mixture of antigens prepared by disintegration of bacteria.
Results: Levels of antibodies against P. gingivalis (OR = 1.48) and A. actinomycetemcomitans
(1.31) associated with periodontitis, as determined by univariable logistic regression analysis.
These antibody levels also associated with CVD (1.17 and 1.37), respectively, However, after
adjusting for other risk factors, including age, smoking, gender, alcohol consumption, over-
weight, and level of education using multivariable logistic regression analysis, only increasing
body mass index (BMI; 1.09), previous smoking (1.99), and increasing age (decades) (2.27)
remained associated with CVD. Increased levels of antibodies against P. gingivalis (1.34)
remained associated with periodontitis after adjusting for other risk factors.
Conclusions: CVD and periodontitis were associated with levels of IgG antibodies to P.
gingivalis or A. actinomycetemcomitans in univariable analyses, but only the association of P.
gingivalis antibody levels with periodontitis reached statistical significance after adjustment
for common confounders. Age, in particular, influenced this relationship.
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Introduction
Periodontitis is a highly prevalent, multifactorial
inflammatory disease induced by biofilms colonizing
the tooth surfaces along the gingival crevice [1]. It
manifests as breakdown of the tooth-supporting tissues
and, if left untreated, periodontitis may cause tooth loss
[1]. The disease affects 50% of the adult population [2]
and is diagnosed on the basis of clinically evident
inflammation, loss of attachment associated with peri-
odontal pocket formation, and alveolar bone loss [3]. In
a recent study, the risk of myocardial infarction was
significantly increased in patients with periodontitis [4].
Accordingly, recent meta-analyses demonstrated signif-
icantly increased risk of developing cardiovascular dis-
ease (CVD) in patients with periodontitis [5,6].
Porphyromonas gingivalis and Aggregatibacter
actinomycetemcomitans are Gram-negative, obligate
anaerobic, and facultative capnophile anaerobic
rods, respectively. Both bacteria are considered
residents of the periodontal biofilms associated
with periodontitis [7–9]. On the basis of structu-
rally and antigenically distinct O-antigens, six ser-
otypes of A. actinomycetemcomitans (a–f) have
been described, with serotype b, particularly the
highly leukotoxic JP2 clone, being the dominant
serotype isolated from patients with early onset
aggressive periodontitis [7,10]. Interestingly, both
A. actinomycetemcomitans and P. gingivalis are cap-
able of inducing strong antibody responses exceed-
ing those found in many other bacterial infections
[11]. Elevated levels of circulating antibodies
against A. actinomycetemcomitans and P. gingivalis
in patients with periodontitis have often been
reported [12–16]; and in a large population of
adults, who participated in the third US National
Health and Nutrition Examination Survey, high
titers of antibodies against P. gingivalis were con-
sistently associated with periodontitis [17].
In relation to CVD, increased levels of circulating
antibodies towards periodontal bacteria, including
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both P. gingivalis and A. actinomycetemcomitans,
have been associated with increased carotid intima-
media thickness [18], and shown to be predictive of
future myocardial infarction [19] and stroke [20].
Also, cross-sectional and case-control studies have
reported positive associations between levels of anti-
bodies against A. actinomycetemcomitans and P. gin-
givalis and the presence of coronary heart disease
within large population-based cohorts [21–23].
According to Pussinen et al. [9], the main deter-
minant of the systemic antibody response to A. acti-
nomycetemcomitans and P. gingivalis is the oral
carriage of these bacteria, whereas the presence or
extent of periodontitis has only a modest modifying
effect on the levels of antibodies against the two
bacteria. Blood levels of antibodies to periodontal
bacteria associated with periodontitis are stable over
time [24,25], and do not change significantly follow-
ing treatment [26]. However, the composition of per-
iodontal biofilm may display variations according to
the state of the disease [24–26].
We hypothesize that blood levels of antibodies to
A. actinomycetemcomitans and P. gingivalis are ele-
vated in subjects with loss of attachment (mean of
2.55 mm or more) as evidence of periodontitis, and
that they correlate with the presence of CVD.
Consequently, the aim was to determine, whether
levels of circulating antibodies to A. actinomycetem-
comitans and P. gingivalis correlate to loss of attach-
ment, as a marker for periodontitis, and CVD. This
hypothesis was tested in 576 participants in the oral
health study of the Danish Health Examination
Survey (DANHES) [27].
Materials and methods
Participants
A subgroup of 4,402 individuals (61% men and 39%
women), aged 18–96 (mean 54) years, among the
18,065 volunteering participants in the DANHES
study had an oral examination carried out in mobile
units by three trained and calibrated dental hygienists,
and filled in a lifestyle and oral health questionnaire
[27]. Only one-fifth of the serum samples from the
4,402 participants from the oral part of DANHES
were available. From this subpopulation, 576 subjects
had both sufficient serum volume and completed ques-
tionnaires. The questionnaires consisted of open-ended
questions, which the participants answered in writing
on paper. As a result, incomplete questionnaires were
not identified upon their submission; however, incom-
plete questionnaires led to exclusion of the subjects in
the present study. In total, 576 participants representing
13 municipalities in Denmark including the larger
Copenhagen area were included in the present study.
Furthermore, a periodontal examination including
half-mouth registration (one upper and one lower
quadrant randomly selected), except third molars,
was completed [27]. The assessments of pocket depths
(PD), bleeding on probing (BOP), and gingival margin
levels were registered at six sites around each tooth.
Gingival recession was registered as a negative value.
Clinical attachment loss (CAL) was calculated as the
sum of the PD and gingival level measurement. The
manual periodontal probe (Model 8-520B; LM-
Instruments, Pargas, Finland) contained pagination at
2, 4, 6, 8, 10, and 12 mm. Periodontitis was defined as
a mean loss of clinical attachment of 2.55 mm or
more, representing a 75th percentile of the entire
study population of the oral part of DANHES [27].
CVD was self-reported in the questionnaire and
defined by a history of myocardial infarction, ischemic
stroke, atherosclerosis, hypertension, high blood cho-
lesterol and/or angina pectoris, or being medically
treated for CVD, as listed above. Information on risk
factors was obtained from the questionnaires and used
in combination with the clinical data from the oral
examination.
Serum samples
Peripheral venous blood samples were collected in
Vacutainer dry tubes (BD Bioscience, Brøndby,
Denmark), and left in the dark for 1 h before
centrifugation at 400 g for 10 min. Serum was
then aliquoted and stored at −80°C until further
analysis.
Ethics
The study was conducted in accordance with the
Helsinki declaration and approved by the regional
ethical committee, the Capital Region of Denmark
(#H-C-2007-0118) and reported to the Danish Data
Authority (#2007-41-15-67). Written informed con-
sent was obtained from all participants.
Bacterial strains
Three strains of P. gingivalis representing serotypes a
(PGF9; originally ATCC 33277), b (PGF7; originally
W83), and c (PGF75; originally HG1025), were obtained
from E. Frandsen, Department of Odontology,
University of Aarhus, Denmark.
Three strains of A. actinomycetemcomitans repre-
senting serotypes a (HK892), b (HK2108 (=Y4)), and
c (HK915) were obtained from M. Kilian, Department
of Biomedicine, University of Aarhus, Denmark). All
three strains of A. actinomycetemcomitans were of the
smooth colony phenotype, which allowed planktonic
growth of the bacteria in liquid culture.
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Preparation of broken cell antigens
Strains of P. gingivalis and A. actinomycetemcomitans
were cultured in 500 mL volumes of plaque [28] and
2×YT [29] liquidmedia incubated at 37°C anaerobically
and in 5% CO2, respectively, until late exponential
phase, as previously described [30,31]. The cultures
were centrifuged at 6,000 g for 30 min at 5°C, and the
isolated bacterial pellet (~2 mL) was suspended in Tris-
buffered saline, pH 7.6, containing 15 mM sodium
azide. The suspension was distributed in 1 mL aliquots
in 2 mL Lysing Matrix A capsules (MP Biomedicals,
Santa Ana, CA) and subjected to 6 × 1 min of disin-
tegration with intermittent cooling in a FastPrep 24
homogenizer (MP Biomedicals) operated at maximal
effect. After centrifugation at 10,000 g for 5 min, super-
natants were transferred to Eppendorf tubes and cen-
trifuged at 20,000 g for 5 min. The final supernatants
were transferred to new tubes.
Antigen preparations from each of the three
strains (serotypes) of P. gingivalis or A. actinomy-
cetemcomitans were compared with respect to level
of plate-coating antigens. Serial threefold dilutions
of each of the three antigen preparations were
coated in parallel in the same enzyme-linked
immunosorbent assay (ELISA) plate (details of
ELISA protocols described below). Subsequently,
all wells were developed equally by incubation
with a fixed dilution of a pool of three sera from
strongly responding aggressive periodontitis
patients [32], followed by addition of enzyme-con-
jugated rabbit antibody to human IgG and enzyme
substrate. Based on this assay, coating antigens for
use in ELISA were produced as an equal volume
mixture of three antigen preparations, each at the
highest dilatation still providing for saturation of
the plate as judged by staining reaction in this
assay. The final preparations of coating antigens
contained proteins of a broad Mr range
(Figure 1). Since natural antibodies are predomi-
nantly of the IgM isotype, potential cross-reactions
with naturally occurring antibodies (against e.g.
heat shock proteins) were limited by the assay’s
specificity for IgG antibodies.
Preparations of bacterial antigens in the form of
whole bacteria
For use in pilot experiments, the bacterial strains
cultured and isolated as described above were washed
in PBS, pH 7.4, and incubated overnight in PBS
containing 0.5% or 1.5% formaldehyde. After wash-
ing three times in PBS, the bacteria were suspended
in PBS at a density of 108 mL−1. For coating of ELISA
plates, suspensions of individual serotypes were
mixed at equal proportions.
ELISA for quantification of bacteria-reactive
antibodies
Antibodies of the IgG class to antigens of P. gingivalis
and A. actinomycetemcomitans were quantified by
ELISA relative to (% of) the level of antibodies in a
reference serum titrated in parallel with test sera in
each plate. The comparability of antibody determina-
tions across different plates was controlled for by
including in each plate the titration of a control
serum. The same set of reference and control sera
were used in all plates testing for antibodies against a
particular bacterial species. Reference as well as con-
trol sera were pools of three sera originating from
Moroccan patients with aggressive periodontitis [32].
These sera were selected on the basis of strong reac-
tions with antigen preparations from one or more of
the three contributing strains. Reference and control
sera did not contain the same serum components.
Before being used in the assay, reference and control
sera were prediluted 1,000-fold so that the OD inter-
val of their titration curves would match the OD
interval of test sera containing less antibody activity.
ELISA protocols were carried out at room tem-
perature throughout. Wells of polystyrene micro-
plates (269620; Nunc, Roskilde, Denmark) were
coated with 100 μL of antigen solution in 10 mM
Tris-buffered saline, pH 7.6, overnight and then
blocked. Tris-buffered saline containing 250 mM
NaCl and 0.15% Tween 20 served as combined wash-
ing and blocking solution and as diluent. Pilot experi-
ments had shown that uncoated plates, when blocked
in this way, did not bind IgG from diluted serum or
from detecting antibody preparations. Subsequently,
test serum samples were applied at four serial four-
fold dilutions (1:80–1:5,120), whereas reference and
control sera were applied at six serial fourfold
Figure 1. Analysis of antigen preparations from A. actinomy-
cetemcomitans (A.a.) and P. gingivalis (P.g.) as used for coat-
ing of ELISA plates.
Lanes of sodium dodecyl sulfate polyacrylamide (7%) gels were
loaded with amounts of antigens equal to those used for coating
of one 96-well plate. Staining with Coomassie Blue (polysaccharides
and LPS) are not visible. Mr markers in kilo Daltons.
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dilutions selected from results of pilot experiments.
After incubation overnight and washing, wells were
incubated with 100 μL of alkaline phosphatase con-
jugated rabbit anti-human IgG (D0336; DAKO,
Glostrup, Denmark) diluted 1:3,000 for 2 h and
then washed. Plates were developed with p--
Nitrophenyl phosphate (P5994; Sigma), 1 mg mL−1
in 0.1 M Na-glycine buffer, pH 10.4, containing
1 mM MgCl2 and 1 mM ZnCl2. After ~45 min, opti-
cal densities (OD) at 405 nm were read with a
Multiscan RC ELISA reader (Labsystems, Helsinki,
Finland). A titration curve for the reference serum
was fitted from a four-parameter logistic model using
the Genesis LITE software package (Labsystems).
Antibody concentrations in test sera were calculated
as the mean of determinations based on OD readings
falling within the middle 80% of the OD range of the
reference serum titration curve. Control serum was
prepared, so that determination of its antibody con-
centration could invariably be based on three OD
readings representing consecutive steps of dilution.
Generally, the data from a plate were considered
valid if the concentration readout for the control
serum did not deviate more than 20% from a value
based on multiple determinations in pilot
experiments.
For 180 of the serum samples, all steps of the ELISA
were done manually using single and eight-channel
tools for dilution and application. With these samples,
dilutions of test sera, references, and controls were
incubated in duplicate wells, analysis being based on
mean values. The remaining 396 samples were ana-
lyzed using a laboratory robot (Biomek 3000;
Beckman Coulter, CA) programmed to carry out all
steps except washing, which was done with hand-held
equipment (Nunc Immunowasher; Nunc, Roskilde,
Denmark). To examine the functional precision of the
robot, five sera representing a broad range of antibody
levels against the bacterial species were titrated sixfold
in one plate against both of the bacteria by the robot.
Antibody determinations were highly reproducible
(CV for sextuplicate antibody analysis of the five sera
ranged from 3.3% to 10.7%; mean, 5.5%). Accordingly,
in titrations of sera by the robot, individual dilutions
were incubated in single wells.
Evaluation of assays for bacteria-reactive
antibodies
To quantify bacteria-reactive antibodies, we initially
adopted a previously described assay based on coat-
ing of polystyrene ELISA plates with whole bacteria
incubated overnight in PBS containing 0.5% formalin
and then washed in PBS [13], modified by using
formalin at 1.5% instead of 0.5% for fixation to
avoid detachment of bacteria. Plates coated with bro-
ken cell antigens from A. actinomycetemcomitans
gave stronger signals than plates coated with the
whole bacterium (Figure 2(A)).
Using mixed broken cell antigens for coating, the
specificity and sensitivity of the ELISA for quantifica-
tion of antibodies towards A. actinomycetemcomitans
was evaluated with sera from clinically and micro-
biologically characterized individuals [32]. First,
serum from a juvenile aggressive periodontitis patient
colonized with the JP2 clone of A. actinomycetemco-
mitans displayed a strong antibody reaction to A.
actinomycetemcomitans antigens, whereas a lower
reaction was seen in serum from a healthy individual
colonized with a non-JP2 clone of this bacterium
(Figure 2(B)). By contrast, sera from two healthy
individuals without detectable A. actinomycetemcomi-
tans colonization displayed very little antibody
(Figure 2(B)).
Next, we examined the ability of our assay to
detect antibodies to bacterial LPS (lipopolysacchar-
ide), which is an immunodominant and serotype-
specific antigen of A. actinomycetemcomitans [33].
LPS from some bacteria have been found to coat
polystyrene plates poorly [34–36]. However, using
broken cell antigens representing individual sero-
types in ELISA, we found that serum from an
aggressive periodontitis patient colonized with the
JP2 clone (serotype b) of A. actinomycetemcomitans
contained antibodies to a serotype b strain at a
level more than 10 times that of antibodies to
antigens from serotype a or serotype c (Figure 2
(C)). This indicates that antibodies to A. actinomy-
cetemcomitans detected by ELISA using broken cell
antigens include antibodies to LPS, and that high
levels of the antibodies reflect colonization or infec-
tion with this bacterium. Similar evaluation of the
data obtained with the ELISA for antibodies to P.
gingivalis was not possible, due to lack of sera from
subjects characterized with respect to colonization
with this bacterium.
Statistics
Risk factors, which should be adjusted for in the
multivariable analyses, were chosen based on avail-
able empirical data in the literature. Subsequently,
univariable analyses served to confirm these risk
factors. Both univariable and multivariable logistic
regression analyses were performed using RStudio
version 0.98.1091, R version 3.1.2. for PC
(RStudio®, Boston, MA). Investigations of interac-
tions between the selected variables were not
included in the analyses due to lack of power.
Possible false specification of the final regression
model was assessed using the Hosmer–Lemeshow
goodness of fit test. P-values <0.05 were considered
statistically significant.
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Results
Patient characteristics
A total of 576 participants were included in the study
(Table 1). Of these, 517 participants were born in
Denmark to Danish parents; 53 were born in
Denmark, to parents who were born in another coun-
try; and six were born in another country than
Denmark, to non-Danish parents. The study popula-
tion consisted of 46% women and 54% men, with a
mean age of 54 years. For further details, see Table 1.
Periodontitis
In the present study, periodontitis, defined as a mean
clinical loss of attachment of 2.55 mm or more, repre-
senting the 75 percentile of the entire study population
of the oral part of DANHES [27], was significantly
associated with IgG antibodies against both P. gingiva-
lis (OR = 1.48 [95% CI: 1.31–1.67]) and A. actinomy-
cetemcomitans (1.31 [1.13–1.52]) using univariable
logistic regression analysis (Table 2).
Moreover, by univariable logistic regression ana-
lyses, periodontitis was associated with increasing age
(decades) (2.25 [1.89–2.70]), with CVD and/or med-
ical treatment for CVD (1.79 [1.26–2.55]), and weekly
alcohol consumption of more than 14 units of alcohol
for women and 21 for men (2.84 [1.61–5.08]).
Current and previous smokers both exhibited
increased risk of having developed periodontitis (cur-
rent smokers: 3.26 [2.02–5.31] and previous smokers:
2.46 [1.66–3.66]). Also, less than 12 years of educa-
tion were associated with periodontitis (ISCED group
1: 2.04 [1.25–3.35], and ISCED group 2: 1.75 [1.11–
2.75]) (Table 2).
However, following adjustment for common risk
factors, only smoking (current smoker: 4.72 [2.61–
8.69] and previous smoker: 2.21 [1.39–3.55]), increas-
ing age (decades; 2.35 [1.90–2.96]), and P. gingivalis-
reactive IgG remained significantly associated with
periodontitis (1.34 [1.17–1.54]) in the multivariable
logistic regression analyses (Table 3).
Cardiovascular disease
In the present study, we broadly defined CVD upon
self-reported previous cardiovascular events, con-
sumption of antihypertensive and/or anticoagulant
Figure 2. Validation of assay sensitivity and specificity to antigen preparations from A. actinomycetemcomitans.
A) Homologous titration curves for serum from a patient with aggressive periodontitis colonized with the JP2 clone (serotype b) of A.
actinomycetemcomitans in wells saturated with disintegrated serotype b bacterial antigen (●) and whole, formalin-treated serotype b bacteria
(■), respectively. B) Comparative titration of sera from four microbiologically and clinically characterized individuals in an ELISA plate coated
with an equivalent mixture of antigens from three strains of A. actinomycetemcomitans representing serotypes a, b, and c. The four sera were
from a patient with aggressive periodontitis colonized with the JP2 clone of A. actinomycetemcomitans (●), a healthy individual colonized by a
non-JP2 clone of A. a. (∎), two healthy individuals without detectable A.a. (▲,▼). C) Comparative titrations of a serum from a patient with
aggressive periodontitis colonized with the JP2 clone (serotype b) of A. actinomycetemcomitans in ELISA wells coated with antigens from either
A. actinomycetemcomitans serotype b (●), serotype a (∎), or serotype c (▲).
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medication, or based on elevated blood pressure mea-
sures in the clinical examination performed in con-
junction with the DANHES study.
Using univariable logistic regression analyses, both
mean loss of attachment of 2.55 mm or more (1.79
[1.26–2.55]) and presence of IgG antibodies to
P. gingivalis (1.17 [1.05–1.31]) or A. actinomycetem-
comitans (1.37 [1.18–1.60]) were significantly asso-
ciated with CVD. Known risk factors for CVD, such
as increasing body mass index (BMI) and diabetes,
were also associated with CVD in this study
(Table 4). Previous smokers were more likely to
have CVD (2.49 [1.70–3.67]), but, surprisingly, cur-
rent smokers did not exhibit a significantly increased
risk of CVD; this may be explained by the age dis-
tribution of current versus previous smokers, the
latter being on average 6 years older. Moreover, for-
mer smokers were 7 years older on average than
never-smokers. Alcohol consumption was not asso-
ciated with increased prevalence of CVD in the
Table 1. Distribution of study population exposure- and covariables by cardiovascular disease (CVD) and
periodontitis.
All CVD Periodontitis
All 576 (100%) 200 (35%) 208 (36%)
Age (mean [SD]), years 54 (14) 62 (10) 61 (9)
Sex
Male 311 (54%) 95 (31%) 104 (33%)
Female 265 (46%) 105 (40%) 104 (39%)
Smoking status
Never 252 (44%) 68 (27%) 60 (24%)
Previous 221 (38%) 106 (48%) 96 (43%)
Current 103 (18%) 26 (25%) 52 (50)
Alcohol consumption, units/week
None 84 (15%) 30 (36%) 27 (32%)
1–7 (women)/1–14 (men) 334 (58%) 110 (33%) 109 (33%)
8–14 (women)/15–21 (men) 101 (18%) 36 (36%) 39 (39%)
>14 (women)/>21 (men) 57 (10%) 24 (42%) 33 (58%)
Diabetes*
HbA1c <6.5% 555 (96%) 186 (34%) 199 (36%)
HbA1c ≥6.5% 21 (4%) 14 (67%) 9 (43%)
ISCED
≤10 years 91 (16%) 37 (41%) 44 (48%)
11–12 years 117 (20%) 41 (35%) 52 (44%)
13–14 years 126 (22%) 33 (26%) 36 (29%)
≥15 years 242 (42%) 89 (37%) 76 (31%)
BMI (mean [SD]) 25 (4) 26 (4) 26 (4)
CAL mm (mean [SD]) 2.52 (1.02) 2.72 (1.06) 3.48 (1.09)
Antibody titers (median [range])
A. actinomycetemcomitans 5 (0–1011) 8 (0–1,011) 7 (0–1,011)
P. gingivalis 82 (2–25,600) 104 (5–25,600) 158 (7–25,600)
BMI, body mass index; CAL, clinical attachment level; CVD, cardiovascular disease; HbA1c, glycosylated hemoglobin; ISCED,
International Standard Classification of Education; SD, standard deviation.
*Defined as HbA1c ≥6.5 in peripheral blood.
Table 2. Periodontitis: univariable logistic regression
analyses.
p-value OR (95% CI)
Age (decades) 5.6 × 10−19 2.25 (1.89–2.70)
Sex (male) 0.150 1.29 (0.91–1.81)
Smoking status
Previous smoker 7.5 × 10−6 2.46 (1.66–3.66)
Current smoker 1.6 × 10−6 3.26 (2.02–5.31)
Alcohol consumption, units/week
0 0.930 0.98 (0.58–1.62)
8–14 (women)/15–21 (men) 0.270 1.30 (0.81–2.05)
>14 (women)/>21 (men) 3.6 × 10−4 2.84 (1.61–5.08)
Diabetes* 0.510 1.34 (0.54–3.23)
ISCED group
1 (≤10 years) 0.004 2.04 (1.25–3.35)
2 (11–12 years) 0.016 1.75 (1.11–2.75)
3 (13–14 years) 0.580 0.87 (0.54–1.39)
BMI 0.057 1.04 (1.00–1.09)
Log A. actinomycetemcomitans Abs 4.3 × 10−4 1.31 (1.13–1.52)
Log P. gingivalis Abs 2.0 × 10−10 1.48 (1.31–1.67)
CVD 0.001 1.79 (1.26–2.55)
Bold values indicate statistical significance (p < 0.05).
Abs, serum IgG antibodies; BMI, body mass index; CVD, cardiovascular
disease; ISCED, International Standard Classification of Education; log,
logarithm transformed.
*Defined as HbA1c ≥6.5 in peripheral blood.
Table 3. Periodontitis: multivariable logistic regression
analyses.
p-value OR (95% CI)
Age (decades) 3.96 × 10−14 2.35 (1.90–2.96)
Sex (male) 0.442 0.84 (0.54–1.30)
Smoking status
Previous smoker 0.001 2.21 (1.39–3.55)
Smoker 3.86 × 10−7 4.72 (2.61–8.69)
Alcohol consumption, units/week
0 0.936 0.98 (0.53–1.78)
8–14 (women)/15–21 (men) 0.959 0.99 (0.57–1.69)
>14 (women)/>21 (men) 0.137 1.65 (0.86–3.22)
Diabetes* 0.476 0.69 (0.24–1.92)
ISCED group
1 (≤10 years) 0.222 1.42 (0.81–2.52)
2 (11–12 years) 0.351 1.30 (0.75–2.26)
3 (13–14 years) 0.850 1.06 (0.60–1.85)
BMI 0.812 1.01 (0.95–1.06)
CVD/CVD medicine 0.188 0.74 (0.47–1.16)
Log A. actinomycetemcomitans Abs 0.812 1.02 (0.85–1.23)
Log P. gingivalis Abs 1.94 × 10−5 1.34 (1.17–1.54)
Bold values indicate statistical significance (p < 0.05).
Abs, serum IgG antibodies; BMI, body mass index; CVD, cardiovascular
disease; ISCED, International Standard Classification of Education; log,
logarithm transformed.
*Defined as HbA1c ≥6.5 in peripheral blood.
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present study population (Table 4). Finally, indivi-
duals with 11–12 years of education were less likely
to have CVD (0.61 [0.38–0.96]).
After adjustment for common risk factors such as
age, smoking, gender, alcohol consumption, over-
weight, and level of education in a multivariable
logistic regression analysis, CVD was no longer sig-
nificantly associated with levels of IgG antibodies
against P. gingivalis (1.04 [0.91–1.18]) or A. actino-
mycetemcomitans (1.13 [0.94–1.36]), nor with period-
ontitis (0.76 [0.48–1.15]) (Table 5).
Risk factors commonly associated with CVD, such
as increased BMI (1.09 [1.04–1.15]), status as a pre-
vious smoker (2.00 [1.28–3.15]), or increasing age
(decades; 2.27 [1.85–3.15]) remained associated with
CVD in the multivariable logistic regression analysis
(Table 5). Moreover, 11–12 years of education or
more remained associated with less CVD after adjust-
ment for other risk factors (0.56 [0.32–0.96]).
Discussion
In the present study we have examined the associa-
tions between periodontitis, CVD, and concentration
of IgG antibodies to P. gingivalis and A. actinomyce-
temcomitans in a cohort of 576 subjects (Table 1),
which is a large cohort in comparison to the existing
literature on this topic [9,19–23]. As determinant of
periodontitis, we used a mean loss of attachment of at
least 2.55 mm [27,37,38]. This may not be a precise
assessment measure of the disease processes asso-
ciated with periodontitis, because it only includes
evidence of past tissue degeneration and not the
current state of the disease.
High titers of antibodies against both P. gingivalis
and A. actinomycetemcomitans were associated with
periodontitis using univariable analyses. However,
only P. gingivalis-reactive antibody titers remained
significantly associated with periodontitis, when the
data were adjusted for common risk factors in multi-
variable logistic regression analyses. This finding sub-
stantiates the positive and independent association of
serum antibody levels against P. gingivalis with peri-
odontitis, which then supports the premise, that
serum antibody levels against P. gingivalis can be
used for investigating potential associations between
periodontitis and other diseases such as CVD. Others
have also successfully used broken cell antigens for
titration of antibodies in serum P. gingivalis-positive
and -negative subjects by ELISA [39].
Periodontitis was associated with self-reported
previous cardiovascular events, antihypertensive
and/or anticoagulant medication, or high blood pres-
sure in univariable analyses. However, these associa-
tions did not reach statistical significance after
adjusting for common risk factors.
In a previous study, Beck et al. found lack of
association between periodontitis and coronary
heart disease, whereas antibody response to several
oral organisms, including P. gingivalis and A. actino-
mycetemcomitans, did associate with periodontitis in
agreement with our findings for antibodies against
P. gingivalis [18]. The authors suggested that the
extent of bacterial exposure may be more important
for systemic health than the burden of periodontitis.
We found that high levels of serum antibodies
against P. gingivalis and A. actinomycetemcomitans
Table 4. Cardiovascular disease: univariable logistic regres-
sion analyses.
p-value OR (95% CI)
Age (decades) 4.4 × 10−19 2.31 (1.93–2.79)
Sex (male) 0.023 1.49 (1.06–2.11)
Smoking status
Previous smoker 3.0 × 10−6 2.49 (1.70–3.67)
Current smoker 0.740 0.91 (0.53–1.53)
Alcohol consumption, units/week
0 0.630 1.13 (0.68–1.86)
8–14 (women)/15–21 (men) 0.610 1.13 (0.70–1.79)
>14 (women)/>21 (men) 0.180 1.48 (0.83–2.62)
Diabetes* 0.004 3.97 (1.62–10.62)
ISCED group
1 (≤10 years) 0,520 1.18 (0.72–1.92)
2 (11–12 years) 0,750 0.93 (0.58–1.47)
3 (13–14 years) 0.042 0.61 (0.38–0.97)
BMI 9.6 × 10−6 1.11 (1.06–1.16)
Log A. actinomycetemcomitans Abs 4.1 × 10−5 1.37 (1.18–1.60)
Log P. gingivalis Abs 0.006 1.17 (1.05–1.31)
Periodontitis† 0.001 1.79 (1.26–2.55)
Bold values indicate statistical significance (p < 0.05).
Abs, serum IgG antibodies; BMI, body mass index; CVD, cardiovascular
disease; ISCED, International Standard Classification of Education; log,
logarithm transformed.
*Defined as HbA1c ≥6.5 in peripheral blood.
†Defined as mean loss of attachment of ≥2.55 mm.
Table 5. Cardiovascular disease: multivariable logistic regres-
sion analyses.
p-value OR (95% CI)
Age (decades) 5.16×10−14 2.27 (1.85–2.84)
Gender (men) 0.683 1.09 (0.71–1.67)
Smoking status
Previous smoker 0.002 2.00 (1.28–3.15)
Current smoker 0.941 1.02 (0.55–1.89)
Alcohol consumption, units/week
0 0.278 1.39 (0.76–2.50)
8–14 (women)/15–21 (men) 0.610 0.87 (0.50–1.50)
>14 (women)/>21 (men) 0.809 1.08 (0.56–2.09)
Diabetes* 0.059 2.84 (0.99–8.80)
ISCED group
1 (≤10 years) 0.119 0.63 (0.35–1.12)
2 (11–12 years) 0.038 0.56 (0.32–0.96)
3 (13–14 years) 0.068 0.60 (0.34–1.03)
BMI 0.001 1.09 (1.04–1.15)
Periodontitis† 0.218 0.76 (0.48–1.18)
Log A. actinomycetemcomitans Abs 0.183 1.13 (0.94–1.36)
Log P. gingivalis Abs 0.605 1.04 (0.91–1.18)
Bold values indicate statistical significance (p < 0.05).
Abs, serum IgG antibodies; BMI, body mass index; CVD, cardiovascular
disease; ISCED, International Standard Classification of Education; log,
logarithm transformed.
*Defined as HbA1c ≥6.5 in peripheral blood.
†Defined as mean loss of attachment of ≥2.55 mm.
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were associated with CVD. However, after adjustment
for common risk factors, the association between CVD
and antibodies against P. gingivalis and A. actinomy-
cetemcomitans lost significance. Adjustment for
increasing age, in particular, influenced the association
observed in the univariable analyses. Previous studies
have consistently adjusted for age when investigating
associations between antibody levels against P. gingi-
valis and A. actinomycetemcomitans, periodontitis, and
CVD [19–23]; our data support the hypothesis that
increasing age is an independent risk factor for loss of
attachment.
The incidence and magnitude of bacteremia are
increased in patients with periodontitis compared
with periodontally healthy subjects [40–43]. The bio-
logical background for the association between peri-
odontitis and CVD has been related to dissemination
of bacteria, such as P. gingivalis and A. actinomyce-
temcomitans and their products during everyday oral
procedures including chewing, tooth brushing, and
flossing. Another potential pathogenic pathway is
spillover of inflammatory mediators from periodontal
tissues to the circulation during such everyday oral
procedures [40]. Notably, both viable oral bacteria
and DNA from oral bacteria have been isolated in
atheromatous plaques distant from the oral cavity
[44–46]. Concomitant changes in endothelial perme-
ability promote the entry and retention of choles-
terol-containing low-density lipoprotein particles in
the artery wall, which may aggravate atherosclerotic
lesions and thus the risk of cardiovascular events
[47]. Moreover, bacteria in the circulation may
induce the release of pro-coagulant factors by
endothelial cells, or even apoptosis, causing rupture
of the atherosclerotic plaque [48].
A. actinomycetemcomitans is particularly implicated
in the pathogenesis of periodontitis in populations of
North African descent. However, A. actinomycetemco-
mitans and P. gingivalis can also be found in low num-
bers in the periodontal biofilms of periodontally healthy
subjects [1]. On that basis, we expected low titers of
antibodies against A. actinomycetemcomitans in the
current study population. Nevertheless, we did find
antibodies againstA. actinomycetemcomitanswith vary-
ing titers (Table 1) in our cohort, despite consisting of
almost only Caucasians. However, these did not associ-
ate with periodontitis after adjustment for common risk
factors. IgG antibodies against P. gingivalis on the other
hand correlated with periodontitis defined as a mean
clinical loss of attachment of 2.55 mm or more
(Table 3).
In conclusion, IgG antibody levels against A. actino-
mycetemcomitans and P. gingivalis were associated with
CVD; however, when other risk factors were taken into
account, statistical significance was lost. IgG antibodies
against P. gingivalis correlated with mean loss of
attachment, which not only substantiates the role of P.
gingivalis in the pathogenesis of periodontitis, but also
suggests that serum IgG antibodies against P. gingivalis
may serve as biomarkers for periodontitis in studies of
associations between periodontitis and systemic
diseases.
Highlights
● Periodontitis is associated with levels of IgG
antibodies to both P. gingivalis and A. actinomy-
cetemcomitans in univariable analyses.
● Cardiovascular disease is associated with levels
of IgG antibodies to both P. gingivalis and A.
actinomycetemcomitans in univariable analyses.
● Levels of IgG antibodies to P. gingivalis are sig-
nificantly associated with periodontitis in multi-
variable logistic regression analyses adjusted for
common confounders such as age, smoking,
gender, and BMI.
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